Moderna’s coronavirus disease 2019 vaccine candidate, mRNA-1273, showed promise in interim data from its phase 1 study.
"I have to admit that in all 39 years of my career as a community pharmacist, I have never seen a drug that was the center of such intense political discussion."
In part 2 of our interview, Devin English, assistant professor at Rutgers School of Health, joined Drug Topics® to discuss how COVID-19 is disproportionately affecting minorities.
A new study found that the use of PCSK9 inhibitors with maximally tolerated statins does not negatively affect the mental cognition of patients.
Here's a roundup of the latest coronavirus-related news.
New digital health products are providing more insight into data and the opportunity for real-time patient interaction.
Heart disease is so common among Americans that it claims 1 life every 37 seconds.
A presentation from the 2020 PQA Annual Meeting examined how employers can engage in improving quality of care for those dependent on opioids.
Pharmacists are often the most accessible health care professionals, which is why a lack of access to pharmacies can have a detrimental effect on patients, especially those with chronic conditions.
Thank you to pharmacy staff on the front lines.